Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide Lead-In Plus Peginterferon for Chronic Hepatitis C
NCT00763568Phase 2Completed
- Sponsor
- Romark Laboratories
- Start
- Aug 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in hepatitis C (HCV), sponsored by Romark Laboratories. Started Aug 2006; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00763568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763568.